MedTrace Logo

Safety and Effectiveness of Intermittent Hypoxia Treatment in Parkinson's Disease

NCT05948761 · Status: COMPLETED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2025-08-11

No results posted yet for this study

Summary

To explore the safety, feasibility and net symptomatic effects of multiple (3x/week, for 4 weeks) intermittent hypoxia treatment sessions in individuals with PD. Secondary outcomes include exploring induction of relevant neuroprotective pathways as measured in serum.

Conditions

  • Parkinson Disease

Interventions

OTHER

Hypoxia through modified hypoxic generator

Commercially available hypoxic generator, modified to allow for convenient remote interventions by non-expert participants.

OTHER

Normoxia through hypoxic generator without active elements

Commercially available hypoxic generator, modified to allow for convenient remote interventions by non-expert participants, without active elements.

Sponsors & Collaborators

  • Radboud University Medical Center

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-07-04
Primary Completion
2024-08-30
Completion
2024-08-30

Countries

  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05948761 on ClinicalTrials.gov